𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Model for end-stage liver disease-sodium and survival benefit in liver transplantation

✍ Scribed by Vitale, Alessandro; Bertacco, Alessandra; Gambato, Martina; D'Amico, Francesco; Morales, Rafael Ramirez; Frigo, Anna C.; Zanus, Giacomo; Burra, Patrizia; Angeli, Paolo; Cillo, Umberto


Book ID
119880498
Publisher
Springer
Year
2012
Tongue
English
Weight
239 KB
Volume
26
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clinically relevant differences in the M
✍ Rhiana Garritsen; Andrei Tintu; Herold Metselaar; Geert Kazemier πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 38 KB πŸ‘ 1 views

With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant

Reply: Clinically relevant differences i
✍ Xavier Xiol; Jose Castellote; Xavier Fuentes-Arderiu πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 37 KB πŸ‘ 1 views

We thank Garritsen et al. 1 for their interest in our article about differences in Model for End-Stage Liver Disease (MELD) and Model for End-Stage Liver Disease-Sodium (MELD-Na) scores determined at 3 different laboratories. 2 We agree that one of the important messages of our article is the import

The pediatric end-stage liver disease (P
✍ Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 1 views

The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr